These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 25652238)
1. Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions. Salmas RE; Yurtsever M; Stein M; Durdagi S Mol Divers; 2015 May; 19(2):321-32. PubMed ID: 25652238 [TBL] [Abstract][Full Text] [Related]
2. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening. Kołaczkowski M; Bucki A; Feder M; Pawłowski M J Chem Inf Model; 2013 Mar; 53(3):638-48. PubMed ID: 23398329 [TBL] [Abstract][Full Text] [Related]
3. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R). Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144 [TBL] [Abstract][Full Text] [Related]
4. The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands. Salmas RE; Stein M; Yurtsever M; Seeman P; Erol I; Mestanoglu M; Durdagi S J Biomol Struct Dyn; 2017 Jul; 35(9):2040-2048. PubMed ID: 27367058 [TBL] [Abstract][Full Text] [Related]
5. Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques. Durdagi S; Salmas RE; Stein M; Yurtsever M; Seeman P ACS Chem Neurosci; 2016 Feb; 7(2):185-95. PubMed ID: 26645629 [TBL] [Abstract][Full Text] [Related]
6. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism. Lane JR; Abramyan AM; Adhikari P; Keen AC; Lee KH; Sanchez J; Verma RK; Lim HD; Yano H; Javitch JA; Shi L Elife; 2020 Jan; 9():. PubMed ID: 31985399 [TBL] [Abstract][Full Text] [Related]
7. Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism. Salmas RE; Yurtsever M; Durdagi S J Biomol Struct Dyn; 2017 Mar; 35(4):738-754. PubMed ID: 26923489 [TBL] [Abstract][Full Text] [Related]
8. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors. Duan X; Zhang M; Zhang X; Wang F; Lei M J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902 [TBL] [Abstract][Full Text] [Related]
9. Studying the catechol binding cavity in comparative models of human dopamine D2 receptor. Sakhteman A; Lahtela-Kakkonen M; Poso A J Mol Graph Model; 2011 Feb; 29(5):685-92. PubMed ID: 21168353 [TBL] [Abstract][Full Text] [Related]
10. Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation. Yap BK; Buckle MJ; Doughty SW J Mol Model; 2012 Aug; 18(8):3639-55. PubMed ID: 22354276 [TBL] [Abstract][Full Text] [Related]
11. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics. Kaczor AA; Jörg M; Capuano B J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852 [TBL] [Abstract][Full Text] [Related]
12. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine. Chandramoorthi GD; Piramanayagam S; Marimuthu P J Mol Model; 2008 Sep; 14(9):849-56. PubMed ID: 18512086 [TBL] [Abstract][Full Text] [Related]
13. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor. Schwalbe T; Kaindl J; Hübner H; Gmeiner P Bioorg Med Chem; 2017 Oct; 25(19):5084-5094. PubMed ID: 28666858 [TBL] [Abstract][Full Text] [Related]
14. The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Shi L; Javitch JA Proc Natl Acad Sci U S A; 2004 Jan; 101(2):440-5. PubMed ID: 14704269 [TBL] [Abstract][Full Text] [Related]
15. Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists. Teeter MM; Froimowitz M; Stec B; DuRand CJ J Med Chem; 1994 Sep; 37(18):2874-88. PubMed ID: 7915325 [TBL] [Abstract][Full Text] [Related]
16. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes. Boeckler F; Lanig H; Gmeiner P J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154 [TBL] [Abstract][Full Text] [Related]